News & Events
Genomic Analysis for All Cancer Patients
Jefferson expands its cancer treatment to analyze each cancer patient's tumor with the newest techniques and help doctors identify cutting edge treatment options.
Simple Test Predicts Obstructive Sleep Apnea in Patients Hospitalized for Heart Failure
Sunil Sharma, M.D. and his team showed that a simple questionnaire, evaluation and pulse-oximetry monitoring can lead to early detection of sleep apnea in patients hospitalized for congestive heart failure.
High Use of Alternative Medicine in Senior Oncology Patients
Many seniors with cancer are also using complementary or alternative medicines that could interfere with their cancer treatment.
Thomas Jefferson University Launches Interactive Curricula Experience
New Curriculum Platform uses iPads to Meet Students Where They Are – On Mobile Devices
Jefferson Physician and Researcher Named Next President of the National Medical Association
Edith Mitchell, M.D., Professor of Medical Oncology at Thomas Jefferson University, will be appointed as President of the National Medical Association (NMA) at the NMA’s 113th Annual Convention and Scientific Assembly in Detroit, Michigan on Tuesday August 4th.
Genomic Fingerprint May Predict Aggressive Prostate Cancer in African Americans
A set of genes could help stratify African American men in need of more aggressive treatment for prostate cancer.
Lynchpin Molecule for the Spread of Cancer Found
A single molecule called DNA-PKcs may drive metastatic processes that turn cancer from a slowly growing relatively benign disease to a killer.
Gregory Kane, M.D., Appointed Chair of the Department of Medicine, Sidney Kimmel Medical College at Thomas Jefferson University
Sidney Kimmel Medical College at Thomas Jefferson University appointed Gregory Kane, M.D., as Chair of the Department of Medicine, effective July 1.
Divided They Conquer – tRNAs Are Segmented Into Fragments In a Manner That Depends on Race, Gender and Tissue, A Finding That May Impact Future Studies Of Disease
In recent years advances in sequencing technology have enabled detailed investigations of the RNA molecules that are active in a cell.
New Family of Small RNAs Boosts Cell Proliferation in Cancer
Rather than cellular trash, half of a transfer RNA (tRNA) molecule appears to actively spur cell proliferation in breast and prostate cancers, suggesting a new role for tRNA and a possible target for a new class of therapy.